| BC | PRESS-RELEASE | neutral | 3/10 | Brunswick Corporation's Freedom Boat Club subsidiary announced the opening of its 450th global location, more than 2.5x | Jun 23, 2026 |
| JFIN | PRESS-RELEASE | bearish | 8/10 | Jiayin Group reported a disastrous Q1 2026 with net revenue plunging 57.4% YoY to RMB756.7M and swinging to a net loss o | Jun 23, 2026 |
| FCFS | PRESS-RELEASE | bullish | 7/10 | FirstCash announces a recommended all-cash acquisition of UK pawn operator Ramsdens Holdings for approximately £206M ($2 | Jun 23, 2026 |
| CELZ | PRESS-RELEASE | bullish | 6/10 | Creative Medical Technology announced FDA clearance to expand its ADAPT Phase 2 trial of CELZ-201 (Olastrocel) for chron | Jun 22, 2026 |
| MU | PRESS-RELEASE | bullish | 6/10 | Micron announced a strategic collaboration with AI leader Anthropic covering memory/storage architecture design, a multi | Jun 22, 2026 |
| IVF | PRESS-RELEASE | bearish | 7/10 | INVO Fertility reported Q1 2026 revenue of $2.02M (+23% YoY) but a massive GAAP EPS miss of -$196.81 vs consensus -$10.0 | Jun 22, 2026 |
| CMND | PRESS-RELEASE | bullish | 6/10 | Clearmind Medicine announced the successful completion of treatment for all 24 participants in Part A of its Phase I/II | Jun 22, 2026 |
| PVLA | PRESS-RELEASE | bullish | 7/10 | Palvella Therapeutics announced that the FDA has granted rolling review for its NDA for QTORIN™ rapamycin to treat micro | Jun 22, 2026 |
| BBIO | PRESS-RELEASE | neutral | 4/10 | BridgeBio announced additional positive data from the Phase 3 PROPEL 3 study of oral infigratinib in achondroplasia will | Jun 22, 2026 |
| REGN | PRESS-RELEASE | bullish | 7/10 | Regeneron announced FDA and EMA acceptance of regulatory applications for cemdisiran, an investigational siRNA therapy f | Jun 22, 2026 |
| NRXP | PRESS-RELEASE | neutral | 4/10 | NRx Pharmaceuticals announced FDA approval of an Expanded Access Protocol for NRX-101 (D-cycloserine/lurasidone) to augm | Jun 22, 2026 |
| TCRX | PRESS-RELEASE | bullish | 7/10 | TScan Therapeutics presented positive Phase 1 Cohort C data for TSC-101, showing 11 of 14 patients achieved complete don | Jun 22, 2026 |
| GXO | PRESS-RELEASE | neutral | 3/10 | GXO Logistics announced it will manage a new distribution center in Ferentino, Italy for Action, the fastest-growing non | Jun 22, 2026 |
| LODE | PRESS-RELEASE | bullish | 6/10 | Comstock Inc. announced the sale of 100% of its mining and mineral assets to Mackay Precious Metals Inc. for over $45 mi | Jun 22, 2026 |
| CMBT | PRESS-RELEASE | bullish | 6/10 | CMB.TECH and Fortescue signed a charter agreement for up to 12 ammonia-capable Newcastlemax vessels, with up to 3 delive | Jun 22, 2026 |
| MT | PRESS-RELEASE | bullish | 6/10 | ArcelorMittal announced a strategic collaboration with AWS to deploy cloud and AI across its steelmaking operations, plu | Jun 22, 2026 |
| GETY | PRESS-RELEASE | bullish | 5/10 | Getty Images announced a display agreement with OpenAI to integrate its licensed visual content into ChatGPT. This partn | Jun 21, 2026 |
| MLTX | PRESS-RELEASE | bullish | 7/10 | MoonLake announced positive Week 52 Phase 3 VELA data for sonelokimab in hidradenitis suppurativa, showing 67.2% HiSCR75 | Jun 21, 2026 |
| CRMT | PRESS-RELEASE | bearish | 7/10 | America's Car-Mart (CRMT) announced an amendment to its credit agreement with Silver Point Finance, providing covenant r | Jun 19, 2026 |
| IOVA | PRESS-RELEASE | neutral | 2/10 | Iovance Biotherapeutics granted inducement stock options covering 140,860 shares to 27 new non-executive employees under | Jun 19, 2026 |
| CAMP | PRESS-RELEASE | neutral | 2/10 | CAMP4 Therapeutics granted inducement stock options for 39,000 shares to three new hires at $3.96 per share, a routine c | Jun 19, 2026 |
| EPRX | PRESS-RELEASE | neutral | 4/10 | Eupraxia Pharmaceuticals reported Q1 2026 EPS of -$0.23, beating consensus estimates of -$0.26 by 9.8%. The filing cover | Jun 19, 2026 |
| TMS | PRESS-RELEASE | bullish | 7/10 | Teamshares Inc. completed its business combination with SPAC Live Oak Acquisition Corp. V, receiving $126.5 million in a | Jun 19, 2026 |
| WTBA | PRESS-RELEASE | neutral | 1/10 | West Bancorporation announced it will report its Q2 2026 results on July 23, 2026. | Jun 19, 2026 |
| ENSG | PRESS-RELEASE | neutral | 2/10 | The Ensign Group declared a quarterly cash dividend of $0.0650 per share, payable by July 31, 2026, to shareholders of r | Jun 19, 2026 |
| IHT | PRESS-RELEASE | neutral | 3/10 | InnSuites Hospitality Trust reported record hotel revenue of ~$2.2M for Q1 FY2027 (Feb–Apr 2026), with consolidated net | Jun 18, 2026 |
| GSBC | PRESS-RELEASE | neutral | 1/10 | Great Southern Bancorp, Inc. announced it will report its Q2 2026 results on July 15, 2026. | Jun 18, 2026 |
| NECB | PRESS-RELEASE | bullish | 4/10 | NorthEast Community Bancorp declared a quarterly cash dividend of $0.25 per share, a $0.05 (25%) increase from the prior | Jun 18, 2026 |
| GNK | PRESS-RELEASE | bearish | 7/10 | Genco Shipping & Trading Limited released preliminary proxy results showing overwhelming shareholder support for its boa | Jun 18, 2026 |
| CRVO | PRESS-RELEASE | bearish | 7/10 | CervoMed announced a registered direct offering of 2.5M shares at $4.00/share, raising $10M in gross proceeds. The dilut | Jun 18, 2026 |